Cytosorbents (CTSO) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $10.57 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
